According to Houshmand, Rowan’s investment will add further momentum to the City of Camden’s revitalization efforts and create a new economic opportunities in the “eds and meds” corridor. The funding will be used, in part, to develop programs, attract top researchers, and provide seed money and start-up costs for researchers.
“As the leading academic health system in South Jersey, Cooper knows how significant medical and bioscience research programs are to developing the next generation of breakthrough treatments and cures,” said Cooper University Health Care Chairman George E. Norcross, III. “Cooper’s Board is in full support of Rowan’s investment and committed to creating a first-rate research program at CMSRU. Attracting top students and health care professionals benefits patients, it benefits our health care system and it provides additional economic opportunities in Camden.”